Pretreatment Drug Use by Patients Entering Drug Treatment Programs during 1971–1973

1976 ◽  
Vol 6 (1) ◽  
pp. 53-71 ◽  
Author(s):  
D. Dwayne Simpson

Patterns of pretreatment drug abuse are described for 28,419 drug users who entered community-based treatment centers that participated in the national Drug Abuse Reporting Program during 1971–1973. Daily heroin use was reported by 60 per cent of the patients; one-third used daily heroin but no nonopioids, one-third used daily heroin and either cocaine, marihuana, or both, and the remainder used other nonopioids (particularly barbiturates) with daily heroin. Polydrug use (three or more nonopioids) was common among the patients who used no heroin or used it infrequently. As expected, polydrug use was most frequent among younger individuals, while daily heroin use (especially without other drugs) was increasingly prevalent among older age groups. Although alcohol use in at least moderate amounts was reported by only a third of the sample, it was most frequent among polydrug users, and was least frequent among daily users of heroin only. Within groups categorized by general patterns of illicit drug use, however, prevalence of alcohol use was higher among males than females, and increased with age.

Author(s):  
Peter Rai

<p>In contemporary society, the full-fledged impact of modernisation and globalisation which has given the free movement of people, goods and money across the countries of the world can be witnessed. This has also opened the economic opportunities among the individuals and communities in the society, which has become a new way of life. Society has changed over the years and activities of the people have also undergone social change. Even the trend of taking drugs has changed with change in society. Traditionally used drugs have been replaced by modern synthetic drugs. The proliferation of pharmaceutical industries, which manufactures narcotic drugs, has, directly and indirectly, encouraged the use and abuse of drugs due to easy access in the market. The epidemic of illicit drug users in the global society has increased significantly and simultaneously related crimes in society. </p><p>Drug abuse is global phenomena. A drug is a biological substance, synthetic or natural, which is taken primarily for non-dietary needs, and it is a substance, which affects the functioning of the mind and body or both. Globally, according to UNODC estimate, in 2009, between 149 and 272 million people, or 3.3% to 6.1% of the population aged 15-64, had used illicit substance once in the previous year. Cannabis and ATS (Amphetamine-type stimulants) are two important drugs which are commonly used worldwide. Within Asia, ATS ranks as the main drug of abuse in Thailand, Japan, Republic of Korea and the Philippines, and also China, Myanmar and Indonesia are in the second rank (UNODC, 2004). Heroin, cocaine and other drugs kill around 0.2 million people each year and also causes health problems with incurable diseases. The European Monitoring Centre for Drug and Drug Addiction (EMCDDA) defines the problem of drug use as, “injecting drug use or long duration regular use of opium, cocaine and amphetamines”. World Health Organisation (WHO), defines drug addiction as a ‘disease,’ and the American Psychiatric Association, define drug abuse as the ‘illicit consumption of any naturally occurring of pharmaceutical substance for the purpose of changing the way, in which a person feels, thinks or behaves, without understanding or taking into consideration the damaging physical and mental side-effects that are caused.'</p>


2000 ◽  
Vol 30 (2) ◽  
pp. 323-334 ◽  
Author(s):  
George S. Yacoubian

Urinalysis is utilized routinely as a tool to validate self-reported drug use. Past research has been inconclusive, however, in confirming strong correlations between urinalysis and self-reported drug use. In the current study, correlation estimates for cocaine and heroin use are derived from adult arrestees surveyed through the Arrestee Drug Abuse Monitoring (ADAM) Program between 1990 and 1997. While the strength of agreement between urinalysis and self-report data varies by both substance and jurisdiction, correlation estimates are consistent over time. These findings suggest that the need for urinalysis should be reassessed.


2019 ◽  
Vol 36 (5) ◽  
pp. 470-481 ◽  
Author(s):  
Willy Pedersen

Norway’s first clinic to treat drug abuse was established in 1961. Most patients had been initiated into drug use through the healthcare system, i.e., in an iatrogenic manner. However, we know little about the drug users from this period. Here, we present an in-depth interview with a woman born into a wealthy family in the early 1920s who developed a heavy morphine addiction. In the course of the interview, she gradually reveals how her husband, who was a physician, as well as two other physicians, who were also erotically attracted to her, had key roles in this development. The narrative illustrates and elaborates how females from the upper strata of society with close links to male physicians may have been at particular risk of opioid misuse in the period before 1960. We now witness a new wave of iatrogenic drug abuse, particularly in the USA. We suggest that experiences from this period may again be relevant.


2016 ◽  
Vol 28 (2) ◽  
pp. 131-145 ◽  
Author(s):  
Trine Filges ◽  
Ditte Andersen ◽  
Anne-Marie Klint Jørgensen

Objectives: This review evaluates the evidence on the effects of functional family therapy (FFT) on drug abuse reduction for young people in treatment for nonopioid drug use. Data and Analysis: We followed Campbell Collaboration guidelines to conduct a systematic review of randomized and nonrandomized trials. Results: The search yielded two studies that met inclusion criteria. Only one study provided numerical results on the effect of FFT on drug use reduction. Conclusions: There is insufficient evidence to allow any conclusion to be drawn on the effect of FFT for young people in treatment for nonopioid drug use. There is a need for more research and particularly for more methodologically rigorous studies in the field of treatment for young drug users.


2001 ◽  
Vol 47 (2) ◽  
pp. 196-220 ◽  
Author(s):  
David Farabee ◽  
Vandana Joshi ◽  
M. Douglas Anglin

For many drug users, the initiation of drug use and the subsequent transition to an addiction career is accompanied by criminal activities. However, the use of general crime and drug use categories often obscures important features of their relationship. In the present study, data from the national Drug Abuse Treatment Outcome Studies sample of 7,189 clients in substance abuse treatment were analyzed to explore the relationships between several addiction career variables and the likelihood of lifetime participation in predatory, victimless, and nonspecialized criminal behaviors. The order of initiation of addiction and criminal careers was significantly related to participation in certain types of crimes, with those beginning criminal careers after beginning their addiction careers being more likely to engage exclusively in victimless than in predatory crimes. Likewise, dependence on cocaine, heroin, or both, relative to alcohol, was associated with greater criminal diversity but a reduced likelihood of participating specifically in predatory crimes.


1998 ◽  
Vol 28 (2) ◽  
pp. 381-394 ◽  
Author(s):  
David Farabee ◽  
Carl G. Leukefeld ◽  
Lon Hays

The Presidential Commission on the Human Immunodeficiency Virus Epidemic (1988) developed a 10-year plan in 1987 that recommended: “Expanded drug abuse treatment programs sufficient to admit all IV drug users who desired services and, until that occurred, short-term detoxification and low-dose methadone for those on waiting lists.” This study presents data collected from a sample of 2,613 out-of-treatment and non-incarcerated injection drug users in 21 U.S. cities to examine their drug-treatment access during the past year. Analyses on injectors who tried but were unable to enter treatment revealed that program-based reasons (e.g., no room, too costly, or stringent admission criteria) are the most commonly given barriers to drug treatment (72%). However, a notable number of injectors (20%) also reported that individual-based reasons are important for not accessing drug treatment. Injectors giving program- and individual-based reasons for not entering treatment are profiled using logistic regression.


Author(s):  
Bryan Timmins

The use of non-prescription drugs is widespread and has a major impact on the health of the individual user and society. In 2006, the British Crime Survey reported that 10% of adults had used one or more illicit drugs in the preceding year, with 3% reporting using a Class A drug. Over 11 million people in the UK are estimated to have used an illicit drug at least once in their lifetime (35%). Drugs abused vary in their intrinsic potential to cause addiction and, with it, more regular and harmful use. Drug users are influenced by trends and fashions, adopting new compounds such as crack cocaine and experimenting with routes of ingestion. Some drugs may become less popular over time, such as LSD, while others, such as cannabis, experience a revival as more potent strains (e.g. Skunk) are developed. A problem drug user is best defined as a person whose drug taking is no longer controlled or undertaken for recreational purposes and where drugs have become a more essential element of the individual’s life. The true economic and social cost of drug use is likely to be substantially greater than the published figures, which are derived from a variety of health and crime surveys which may overlook vulnerable groups such as the homeless. The majority of non-prescription drugs used in the UK are illegal and covered by the Misuse of Drugs Act 1971. The drugs most commonly abused gave rise in 2003–4 to an estimated financial cost in England and Wales of 15.4 billion pounds to the economy, with Class A drugs such as heroin and cocaine accounting for the majority of this. Some 90% of the cost is due to drug-related crime, with only 3% (£488 million) due to health service expenditure, which is mainly spent on inpatient care episodes. This still represents a major health pressure, which in 2006–7 amounted to 38 000 admissions, in England, for primary and secondary drug-related mental or behavioural problems, and over 10 000 admissions recorded for drug poisoning. Clinicians in all specialities can expect to encounter harmful drug use, especially those working in primary care, A & E, and psychiatric services. Presenting problems are protean, ranging from mood disorders, delirium, and psychosis to sepsis, malnutrition, and hepatitis. Blood-borne infections such as hepatitis C and HIV are widespread, as contaminated needles and syringes are shared by up to a quarter of problem drug users. Even smoking drugs such as crack cocaine can lead to increased transmission of hepatitis C through oral ulceration and contact with hot contaminated smoking pipes. Amongst the UK population, over half of IV drug users have hepatitis C, a quarter have antibodies to hepatitis B, and, by 2006, 4662 had been diagnosed with HIV. Non-prescription drug abuse is a leading cause of death and morbidity amongst the young adult population (those aged 16–35). In 2006 there were 1573 deaths where the underlying cause was poisoning, drug abuse, or dependence on substances controlled under the Misuse of Drugs Act. The vast majority (79%) were male. Young men, in particular, are at greater risk of violent death through associated criminal activity such as drug supplying and from deliberate and accidental overdose. The male-to-female ratio for deaths associated with mental and behavioural disorder is 6:1.


Sign in / Sign up

Export Citation Format

Share Document